Central Garden & Pet Company

Valuation Analysis

About the Company

Central Garden & Pet Company produces and distributes various products for the lawn and garden, and pet supplies markets in the United States. It operates through two segments: Pet and Garden. The Pet segment provides dog and cat supplies, such as dog treats and chews, toys, pet beds and containment, grooming items, waste management, and training pads; supplies for aquatics, small animals, reptiles, and pet birds, including toys, enclosures, habitats, bedding, and food and supplements; products for equine and livestock; animal and household health and insect control products; aquariums and terrariums, including fixtures and stands, water conditioners and supplements, water pumps and filters, and lighting systems and accessories; and live fish and small animals, as well as outdoor cushions.

Central Garden & Pet Company Stock at a Glance

Central Garden & Pet Company (CENTA) is currently trading at $37.77 with a market capitalization of $2.4B. The trailing P/E ratio stands at 13.73x, with a forward P/E of 12.2x. The 52-week range spans from $25.97 to $38.15; the current price is 1% below the yearly high. Year-over-year revenue growth stands at +8.7%. The net profit margin stands at 5.42%.

💰 Dividend

Central Garden & Pet Company currently does not pay a dividend. The company typically reinvests its earnings into growth initiatives and product development.

📊 Analyst Rating

4 analysts rate Central Garden & Pet Company (CENTA) on consensus: Buy. The average price target is $43.50, implying +15.17% from the current price. Analyst price targets range from $32.00 to $50.00.

Central Garden & Pet Company: The Investment Case in Detail

Central Garden & Pet Company (CENTA) operates in the Consumer Defensive — specifically Packaged Foods — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Earnings growth of 30.6% is outpacing revenue, a sign of operational leverage — fixed costs are being absorbed across a larger base. Wall Street consensus sits at Buy with an average price target implying roughly 15.17% upside from current levels — analyst sentiment is firmly constructive. Our valuation screen flags the stock as undervalued relative to its fundamentals — multiples are running below where the cash flow profile would normally justify.

Valuation in Context

The EV/EBITDA multiple of 8.66x is below the historical equity-market average — strategic acquirers would find the cash-flow profile attractive at this level.

What to Watch Next

• The forward P/E of 12.2x is meaningfully below the trailing 13.73x — analysts expect earnings to step up; the next earnings release is the test.
• The share is trading at 96.9% of its 52-week range — a break above the recent high opens technical upside, a failure here often invites profit-taking.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

Price trades above both the 50- and 200-day moving averages, with 50d above 200d — a classic bullish setup (golden-cross alignment).

Risk Profile

The data points to relatively defensive market behavior.

Trading Data

Related Stocks in the Same Sector

Where can I buy Central Garden & Pet Company?

Compare top-rated brokers — low fees, trusted providers, fully regulated.